Internal Medicine, Rheumatology · Gainesville, GA
NPI
1467891564
Since 2013
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
700 S Enota Dr NE
Gainesville, GA, 30501
Phone (705) 313-7117
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.2M
125,132 services
Medicare patients, 2024
416
Average age 72
Drug cost, 2024
$6.2M
4,636 prescriptions
Company payments, 2025
$2,997
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephen M Elmore was code J3262 (injection, tocilizumab, 1 mg), 45,970 times for 19 patients. In total Stephen M Elmore billed 125,132 services in 63 codes, and Medicare paid $1.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-07-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3262 Injection, tocilizumab, 1 mg | Office | 45,970 | 19 | $4.70 | $216K |
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 40,800 | 43 | $3.57 | $146K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 11,500 | 21 | $9.04 | $104K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 9,550 | 37 | $33.14 | $317K |
| 99214 Office E&M - Established | Office | 732 | 298 | $86.42 | $63K |
| 36415 Venipuncture Blood Collection | Office | 498 | 262 | $8.60 | $4,282 |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 375 | 11 | $0.23 | $85.98 |
| 96413 Chemotherapy Administration | Office | 363 | 102 | $94.50 | $34K |
| 85025 Blood Count | Office | 299 | 215 | $7.58 | $2,266 |
| 86140 Clinical Chemistry | Office | 298 | 224 | $5.06 | $1,508 |
| 80053 Clinical Chemistry | Office | 298 | 218 | $10.31 | $3,072 |
| 85652 Clinical Chemistry | Office | 298 | 224 | $2.64 | $787 |
| 96401 Chemotherapy Administration | Office | 232 | 56 | $51.84 | $12K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 157 | 112 | $12.99 | $2,039 |
| 73120 X-ray - Upper Extremity | Office | 149 | 61 | $10.73 | $1,599 |
By year: 2022 $744K for 62,674 services; 2023 $600K for 65,848 services; 2024 $1.2M for 125,132 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 498 | 262 | $8.60 | $4,282 |
| 85025 Blood Count | 299 | 215 | $7.58 | $2,266 |
| 85652 Clinical Chemistry | 298 | 224 | $2.64 | $787 |
| 80053 Clinical Chemistry | 298 | 218 | $10.31 | $3,072 |
| 86140 Clinical Chemistry | 298 | 224 | $5.06 | $1,508 |
| 83516 Immunoassay | 66 | 33 | $11.30 | $746 |
| 86160 Immunoassay | 37 | 16 | $11.76 | $435 |
| 86431 Immunoassay | 33 | 33 | $5.56 | $183 |
| 86200 Immunoassay | 31 | 31 | $12.69 | $393 |
| 86480 Immunoassay | 24 | 24 | $60.74 | $1,458 |
Medicare prescription drug claims, 2024
In 2024, the drug Stephen M Elmore prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 949 prescriptions and refills. In total Stephen M Elmore wrote 4,636 Medicare prescriptions that cost $6.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 949 | 2,198 | 259 | $40K |
| Methotrexate Methotrexate Sodium | 879 | 1,936 | 223 | $18K |
| Prednisone Generic | 633 | 1,046 | 220 | $3,889 |
| Humira(Cf) Pen Adalimumab | 190 | 190 | 23 | $1.3M |
| Enbrel Sureclick Etanercept | 171 | 176 | 25 | $1.3M |
| Orencia Clickject Abatacept | 161 | 161 | 23 | $915K |
| Meloxicam Generic | 116 | 240 | 38 | $604 |
| Sulfasalazine Generic | 102 | 240 | 24 | $2,734 |
| Tramadol Hcl Generic | 69 | 69 | 12 | $307 |
| Allopurinol Generic | 65 | 179 | 21 | $703 |
| Rinvoq Upadacitinib | 64 | 64 | Under 11 | $402K |
| Leflunomide Generic | 63 | 127 | 18 | $2,320 |
| Tizanidine Hcl Generic | 62 | 90 | 21 | $269 |
| Folic Acid Generic | 59 | 163 | 18 | $474 |
| Febuxostat Generic | 59 | 102 | Under 11 | $7,224 |
Brand drugs: 1,101 claims; generic drugs: 3,535 claims; opioid claims: 92.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stephen M Elmore $2,997 ($2,997 in general payments such as food, travel and fees) from 23 companies. The largest payer was Abbvie Inc. with $854.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 51 | $854 |
| Amgen Inc. AMGN | 25 | $511 |
| UCB, Inc. UCB.BR | 16 | $275 |
| Novartis Pharmaceuticals Corporation NVS | 10 | $189 |
| Pfizer Inc. PFE | 7 | $157 |
| Genzyme Corporation SNY | 5 | $134 |
| Janssen Biotech, Inc. JNJ | 5 | $95.92 |
| GlaxoSmithKline, LLC. GSK | 5 | $89.82 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $84.29 |
| Aurinia Pharma U.S., Inc. AUPH | 4 | $77.93 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.